Market closedADR

Haleon/$HLN

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Haleon

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Ticker

$HLN
Sector
Consumer Staples

Trading on

NYSE

Industry

Personal Care Products
Headquarters
Weybridge, United Kingdom

Employees

25,408
Website
www.haleon.com

Haleon Metrics

BasicAdvanced
$41B
56.83
$0.16
0.19
$0.16
1.16%

$41B

0.19

$10.67

$7.89

6.9M

$0.16

54.175

6.26%

56.827

6.096

2.03

-3.44

1.74%

1.16%

-0.65%

-2.93%

What the Analysts think about Haleon

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Haleon stock.

Haleon Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Haleon Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-

Haleon News

AllArticlesVideos
Pfizer intends to cut stake in Sensodyne-maker Haleon to 7.3%, says bookrunner

Pfizer intends to cut stake in Sensodyne-maker Haleon to 7.3%, says bookrunner

Reuters·12 hours ago
Haleon: Guidance Implies Uncertainty Around Flu Season

Haleon: Guidance Implies Uncertainty Around Flu Season

Seeking Alpha·1 month ago
Dividend Income: Lanny's October 2024 Summary

Dividend Income: Lanny's October 2024 Summary

Seeking Alpha·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $HLN

$

Sign up or log in to buy
Capital at risk
Market closedADR

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Haleon stock?

Haleon (HLN) has a market cap of $41B as of January 15, 2025.

What is the P/E ratio for Haleon stock?

The price to earnings (P/E) ratio for Haleon (HLN) stock is 56.83 as of January 15, 2025.

Does Haleon stock pay dividends?

Yes, the Haleon (HLN) stock pays dividends to shareholders. As of January 15, 2025, the dividend rate is $0.15798 and the yield is 1.16%. Haleon has a payout ratio of 0% on a trailing twelve-month basis.

When is the next Haleon dividend payment date?

The next Haleon (HLN) dividend payment date is unconfirmed.

What is the beta indicator for Haleon?

Haleon (HLN) has a beta rating of 0.19. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.